Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds William Blair Initiates Coverage On POINT Biopharma Global with Outperform Rating

William Blair Initiates Coverage On POINT Biopharma Global with Outperform Rating

William Blair analyst Andy Hsieh initiates coverage on POINT Biopharma Global (NASDAQ:PNT) with a Outperform rating.

July 6, 2022

1 minute read

William Blair analyst Andy Hsieh initiates coverage on POINT Biopharma Global (NASDAQ:PNT) with a Outperform rating.

Mizuho Maintains Neutral on Texas Instruments, Raises Price Target to $165

January 25, 9:53 AM

Mizuho analyst Vijay Rakesh maintains Texas Instruments (NASDAQ:TXN) with a Neutral and raises the price target from $159 to $165.

July 21, 8:42 AM

Morgan Stanley analyst Stephen Byrd maintains DTE Energy (NYSE:DTE) with a Overweight and raises the price target from $124 to $131.

September 1, 11:07 AM

Analysts have provided the following ratings for Expensify (NASDAQ:EXFY) within the last quarter:

May 18, 1:13 AM

Are we on the brink of an AI apocalypse? According to a recent survey, most U.S. citizens share Elon…